Clincosm LogoSign in Get a demo

Major Depressive Disorder

Showing NaN - NaN of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

MDD Trial in United States (Lumateperone, Placebo)

Recruiting
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +16 more
Apr 7, 2022

MDD Trial in Worldwide (Lumateperone)

Enrolling by invitation
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +44 more
Apr 7, 2022

MDD Trial in United States (Levomilnacipran ER, Fluoxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Levomilnacipran ER
  • +2 more
  • Little Rock, Arkansas
  • +50 more
Mar 1, 2022

Bipolar Depression, MDD Trial in Worldwide (Lumateperone, Placebos)

Recruiting
  • Bipolar Depression
  • Major Depressive Disorder
  • Garden Grove, California
  • +41 more
Feb 28, 2022

MDD Trial in United States (AXS-05, Bupropion)

Completed
Has Results
  • Major Depressive Disorder
  • Beverly Hills, California
  • +3 more
Sep 22, 2021

MDD Trial in United States (Antidepressant + SPD489 (lisdexamfetamine dimesylate), Antidepressant + )

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + SPD489 (lisdexamfetamine dimesylate)
  • Antidepressant + placebo
  • Newport Beach, California
  • +14 more
Jun 8, 2021

MDD Trial in Australia, Puerto Rico, United States (ALKS 5461, ALKS 5461 Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • ALKS 5461 Placebo
  • Tucson, Arizona
  • +34 more
Mar 15, 2021

MDD Trial in Puerto Rico, United States (AGO178)

Terminated
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +97 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +44 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +47 more
Dec 15, 2020

MDD Trial in Puerto Rico, United States (Agomelatine, paroxetine, )

Completed
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +46 more
Dec 15, 2020

MDD Trial in Puerto Rico, United States (Placebo, Levomilnacipran, Fluoxetine)

Completed
Has Results
  • Major Depressive Disorder
  • Placebo
  • +2 more
  • Dothan, Alabama
  • +48 more
Aug 19, 2020

Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)

Completed
Has Results
  • Depression
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Beverly Hills, California
  • +34 more
Dec 23, 2019

MDD Trial in United States (Placebo, Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Imperial, California
  • +51 more
Dec 6, 2019

MDD Trial in Canada, United States (Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +55 more
Sep 10, 2019

MDD Trial in Puerto Rico, United States (Cariprazine, Antidepressant Therapy (ADT))

Completed
Has Results
  • Major Depressive Disorder
  • Tucson, Arizona
  • +89 more
Jul 29, 2019

MDD Trial in Canada, United States (ALKS 5461)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Jacksonville, Florida
  • +8 more
Aug 2, 2019

MDD Trial in Worldwide (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Birmingham, Alabama
  • +43 more
Aug 2, 2019

MDD Trial in Bulgaria, United States (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Little Rock, Arkansas
  • +57 more
May 31, 2019

MDD Trial in United States (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Tucson, Arizona
  • +26 more
Apr 26, 2019

MDD Trial in United States (Antidepressant + , Antidepressant + cariprazine (0.1-0.3 mg/day), Antidepressant + cariprazine (1-2

Completed
Has Results
  • Major Depressive Disorder
  • Antidepressant + placebo
  • +2 more
  • Phoenix, Arizona
  • +40 more
Feb 12, 2019

MDD Trial in Mexico, United States (desvenlafaxine succinate sustained release, fluoxetine, )

Completed
Has Results
  • Major Depressive Disorder
  • desvenlafaxine succinate sustained release
  • +2 more
  • Dothan, Alabama
  • +42 more
Jan 2, 2019

MDD Trial in Worldwide (ALKS 5461)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Birmingham, Alabama
  • +157 more
Nov 21, 2018

MDD Trial in Worldwide (Placebo, Cariprazine)

Completed
Has Results
  • Major Depressive Disorder
  • Garden Grove, California
  • +71 more
Mar 29, 2018